When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
VIE - FDA OKs Viela Bio's inebilizumab for rare nervous system disorder
Viela Bio Inc.
The FDA approves Viela Bio's (NASDAQ:VIE) Uplizna (inebilizumab-cdon) for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adults who harbor an antibody called anti-aquaporin-4 (AQP4).
More news on: Viela Bio, Inc., Healthcare stocks news, Stocks on the move,